{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:19:27Z","timestamp":1792811967684,"version":"4.5.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The haemagglutination inhibition assay (HAI) and the virus microneutralisation assay (MN) are long-established methods for quantifying antibodies against influenza viruses.  Despite their widespread use, both assays require standardisation to improve inter-laboratory agreement in testing.  The FLUCOP consortium aims to develop a toolbox of standardised serology assays for seasonal influenza. Building upon previous collaborative studies to harmonise the HAI, in this study the FLUCOP consortium carried out a head-to-head comparison of harmonised HAI and MN protocols to better understand the relationship between HAI and MN titres, and the impact of assay harmonisation and standardisation on inter-laboratory variability and agreement between these methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this paper, we present two large international collaborative studies testing harmonised HAI and MN protocols across 10 participating laboratories.  In the first, we expanded on previously published work, carrying out HAI testing using egg and cell isolated and propagated wild-type (WT) viruses in addition to high-growth reassortants typically used influenza vaccines strains using HAI.  In the second we tested two MN protocols: an overnight ELISA-based format and a 3-5 day format, using reassortant viruses and a WT H3N2 cell isolated virus.  As serum panels tested in both studies included many overlapping samples, we were able to look at the correlation of HAI and MN titres across different methods and for different influenza subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We showed that the overnight ELISA and 3-5 day MN formats are not comparable, with titre ratios varying across the dynamic range of the assay. However, the ELISA MN and HAI are comparable, and a conversion factor could possibly be calculated.  In both studies, the impact of normalising using a study standard was investigated, and we showed that for almost every strain and assay format tested, normalisation significantly reduced inter-laboratory variation, supporting the continued development of antibody standards for seasonal influenza viruses.  Normalisation had no impact on the correlation between overnight ELISA and 3-5 day MN formats.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2023.1155552","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T01:20:36Z","timestamp":1681780836000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study"],"prefix":"10.3389","volume":"14","author":[{"given":"Joanna","family":"Waldock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond J.","family":"Remarque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sammy","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Hoschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Sediri-Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M.","family":"Trombetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Montomoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Lapini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Lartey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Facchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rita","family":"Castrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Friel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Ollinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Caillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nedzad","family":"Music","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Palladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othmar G.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the FLUCOP consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"B1","unstructured":"Influenza (Seasonal)2018"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00567-21","article-title":"Assay harmonization and use of biological standards to improve the reproducibility of the hemagglutination inhibition assay: A flucop collaborative study","volume":"6","author":"Waldock","year":"2021","journal-title":"mSphere"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza a hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Sci (New York NY)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Sci (New York NY)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12333","article-title":"Optimisation of a micro-neutralisation assay and its application in antigenic characterisation of influenza viruses","volume":"9","author":"Lin","year":"2015","journal-title":"Influenza other Respir Viruses"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00458-10","article-title":"Neuraminidase receptor binding variants of human influenza a(H3n2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: A role in virus attachment","volume":"84","author":"Lin","year":"2010","journal-title":"J Virol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1006\/viro.2001.1121","article-title":"Hemagglutinin residues of recent human a(H3n2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes","volume":"289","author":"Medeiros","year":"2001","journal-title":"Virology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2000.0679","article-title":"Change in receptor-binding specificity of recent human influenza a viruses (H3n2): A single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides","volume":"278","author":"Nobusawa","year":"2000","journal-title":"Virology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20157","article-title":"Antigenic characterisation of influenza b virus with a new microneutralisation assay: Comparison to haemagglutination and sequence analysis","volume":"74","author":"Ansaldi","year":"2004","journal-title":"J Med Virol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(85)90105-9","article-title":"Alterations in the hemagglutinin associated with adaptation of influenza b virus to growth in eggs","volume":"143","author":"Robertson","year":"1985","journal-title":"Virology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20178","article-title":"Antigenic alteration of influenza b virus associated with loss of a glycosylation site due to host-cell adaptation","volume":"74","author":"Saito","year":"2004","journal-title":"J Med Virol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.019","article-title":"Reproducibility of serology assays for pandemic influenza H1n1: Collaborative study to evaluate a candidate who international standard","volume":"30","author":"Wood","year":"2012","journal-title":"Vaccine"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.02.039","article-title":"Comparison of neutralising antibody assays for detection of antibody to influenza a\/H3n2 viruses: An international collaborative study","volume":"25","author":"Stephenson","year":"2007","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3201\/eid1508.081754","article-title":"Reproducibility of serologic assays for influenza virus a (H5n1)","volume":"15","author":"Stephenson","year":"2009","journal-title":"Emerging Infect Dis"},{"key":"B15","unstructured":""},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/cvi.00613-15","article-title":"Standardization of hemagglutination inhibition assay for influenza serology allows for high reproducibility between laboratories","volume":"23","author":"Zacour","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.02.077","article-title":"Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1n1 influenza vaccines\u2013an effective eu regulatory approach","volume":"30","author":"Wagner","year":"2012","journal-title":"Vaccine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410x(94)90056-6","article-title":"Comparison of influenza serological techniques by international collaborative study","volume":"12","author":"Wood","year":"1994","journal-title":"Vaccine"},{"key":"B19","unstructured":"Serological diagnosis of influenza by microneutralization assay world health organisation2010"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.13.1.54-57.1981","article-title":"Ether treatment of type b influenza virus antigen for the hemagglutination inhibition test","volume":"13","author":"Monto","year":"1981","journal-title":"J Clin Microbiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1129765","article-title":"An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A flucop study","volume":"14","author":"Waldock","year":"2023","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1017\/s0022172400022610","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and b viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J Hygiene"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.01.088","article-title":"Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: Good correlation but poor agreement","volume":"38","author":"Sicca","year":"2020","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/cvi.00278-15","article-title":"International laboratory comparison of influenza microneutralization assays for a(H1n1)Pdm09, a(H3n2), and a(H5n1) influenza viruses by consise","volume":"22","author":"Laurie","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12591","article-title":"Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and Elisa to detect antibody levels against seasonal influenza viruses","volume":"12","author":"Trombetta","year":"2018","journal-title":"Influenza other Respir Viruses"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12408","article-title":"A comparison of hemagglutination inhibition and neutralization assays for characterizing immunity to seasonal influenza a","volume":"10","author":"Truelove","year":"2016","journal-title":"Influenza other Respir Viruses"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01677","article-title":"Protective antibodies against influenza proteins","volume":"10","author":"Padilla-Quirarte","year":"2019","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2014.04.009","article-title":"Broadly neutralizing influenza hemagglutinin stem-specific antibody Cr8020 targets residues that are prone to escape due to host selection pressure","volume":"15","author":"Tharakaraman","year":"2014","journal-title":"Cell Host Microbe"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1155552\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T01:20:45Z","timestamp":1681780845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1155552\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2023.1155552"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1155552","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,18]]},"article-number":"1155552"}}